University of Kentucky Markey Cancer Center Researcher Jessica Blackburn has earned a prestigious National Institutes of Health's New Innovator Award, a grant totaling $1.5 million over five years to fund pediatric cancer research.

markey-research-article1.png
markey-research-article1.png

The National Institutes of Health has awarded a five year, $2.88 million grant to a Sanders-Brown Center on Aging researcher to study a drug's potential to prevent Alzheimer's disease.

Ai-Ling Lin.jpg
Ai-Ling Lin.jpg

A fundraising effort that began with an impassioned plea from one extension homemaker to her peers has positively impacted Kentucky women and the University of Kentucky for the past 40 years.

17-10-04 Pavilk and Homemakers - Photo.jpg
17-10-04 Pavilk and Homemakers - Photo.jpg

On October 3, 2017, Cheavar Blair successfully earned his Doctoral Degree. By doing so, he has become the first African-American male in the history of the Department of Physiology to be awarded a PhD. Congratulations Dr. Blair!

THE MECHANICAL PROPERTIES OF NON-FAILING AND FAILING HUMAN MYOCARDIUM

Doctoral Committee Members
Dr. Ken Campbell
Department of Physiology

Dr. John McCarthy
Department of Physiology

Dr. Tim McClintock
Department of Physiology

Webslider.jpg
Webslider.jpg

Check Out the New Limited Submissions Portal!

UK Research has just launched a new online limited submissions portal at Limited Submissions Opportunities on the Proposal Development Office website.

Research Financial Services has been leading a team with Enterprise Applications Group (EAG) and Office of Sponsored Projects Administration to create efficiency in processing subaward invoices, while meeting federal compliance standards. The EAG team developed an outstanding program to establish electronic approval for subaward invoices. The pilot has successfully been completed and effective September 29, all subaward invoices will be under the new process.  

THE CENTER FOR BIOMEDICAL RESEARCH EXCELLENCE ON OBESITY AND CARDIOVASCULAR DISEASES (COCVD) FUNDING OPPORTUNITY 

Of the 14 million cancer survivors in the United States, a significant number experience a serious side effect called chemotherapy-induced cognitive impairment (CICI). While easily recognized, little is known about the etiology of this condition, also known informally as “chemo brain.” CICI can significantly reduce patients’ quality of life with serious, even devastating, symptoms such as memory lapses, difficulty concentrating, negative impacts on multitasking, confusion and fatigue.

ThinkstockPhotos-590283154.jpg
ThinkstockPhotos-590283154.jpg